MIR3144

Across TCGA pan-cancer cohorts, MIR3144 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR3144 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR3144 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3144 expression acts as an unfavorable survival marker.

CESC, DLBC, and BLCA are the cancer types where MIR3144 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.068	0.875	<.001	108	view →
DLBC	OS	Tertile	II,III,IV	0.099	0.731	.005	90	view →
BLCA	DFS	Tertile	IV	0.123	0.483	<.001	36	view →
SARC	OS	Tertile	All	0.162	0.772	<.001	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	27	view →
KIRC	DFS	Tertile	IV	0.100	0.631	.024	18	view →
BRCA	OS	Tertile	II,III,IV	0.183	0.567	.018	12	view →
SKCM	DFS	Tertile	All	0.241	0.640	.033	9	view →
LIHC	DFS	Tertile	All	0.054	0.553	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR3144–CESC (OS)

Open the CESC breakdown →